Skip to search formSkip to main contentSkip to account menu

lorcainide

Known as: 4'-chloro-N-(1-isopropyl-4-piperidyl)-2-phenylacetanilide, N-(4-chlorophenyl)-N-(1-(1-methylethyl)- 4-piperidinyl)benzeneacetamide.HCl, lorcainid 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
1984
Review
1984
SummarySynopsis: Lorcainide1 is a type I antiarrhythmic drug of the local anaesthetic type. It can be given either intravenously… 
1984
1984
Lorcainide, a new type I antiarrhythmic agent, was compared to quinidine in respect to antiarrhythmic efficacy and clinical… 
1984
1984
Electrophysiologic effects of intravenous lorcainide and its major metabolite, norlorcainide, were examined in 18 anesthetized… 
1980
1980
: The long-term anti-arrhythmic efficacy of lorcainide (R15 889) was studied in 20 ambulatory postmyocardial infarction patients… 
1980
1980
A 68-year-old patient developed increasingly frequent episodes of ventricular and supraventricular arrhythmias over the past five… 
1980
1980
The effect of oral N-(4-chlorophenyl)-N-[1-(1-methylethyl)-4-piperidinyl]benzene acetamide (lorcainide) was studied in 12… 
1979
1979
The disposition and the antiarrhythmic effect of lorcainide (R 15,889) were investigated in 11 patients with ventricular… 
1979
1979
Lorcainide is a new antiarrhythmic agent which effectively suppresses ventricular premature contractions. Its… 
1978
1977
1977
The anti-arrhythmic properties of a new drug, lorcainide, have been evaluated. Lorcainide is highly efficient for the treatment…